Clinical trials: TNM Stage II-IV Breast Cancer
HER2-positive Breast Cancer, TNM Stage II-IV Breast Cancer
CharactHer. ICORG 12-09, V3
Primary Objective: The primary aim of the study is: 1.To identify and validate a panel of molecular and cytogenetic biomarkers able to predict Durable Complete Response (DCR) after chemotherapy and trastuzumab in patients with…
- Trial name
- NCT01722890
- Where
- 2 sites in Ireland, Italy
- Volunteers
- 130 people
- Sponsor
- Cancer Trials Ireland